Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model (Q67517790)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1992

Language	Label	Description	Also known as
English	Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model	scientific article published on 01 January 1992

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

prostate cancer

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

author name string

T Yano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

J Pinski

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

K Szepeshazi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

S R Milovanovic

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

K Groot

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

297-310

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivo. A histological and immunohistochemical study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Radioimmunoassay for octapeptide analogs of somatostatin: measurement of serum levels after administration of long-acting microcapsule formulations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Paradoxical Effects of d-Trp6-Luteinizing Hormone-Releasing Hormone on the Hypothalamic-Pituitary-Gonadal Axis in Immature Female Rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Evaluation of receptors for somatostatin in various tumors using different analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Relationship between tumor size and the curability of metastatic prostatic cancer by surgery alone or in combination with adjuvant chemotherapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Prostatic epidermal growth factor receptors and their regulation by androgens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

The effect of SMS 201-995, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

The presence of LHRH-like receptors in Dunning R3327H prostate tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Inhibition of the pituitary-gonadal axis by a single intramuscular administration of D-Trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Histological changes in Dunning prostate tumors and testes of rats treated with LH-RH antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Effects of gonadal steroids on somatotroph function in the rat: analysis by the reverse hemolytic plaque assay

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Prolonged inhibition of luteinizing hormone and testosterone levels in male rats with the luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/PROS.2990200405

Identifiers

10.1002/PROS.2990200405

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1351672 AND SRC:MED&resulttype=core&format=json

14 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67517790&oldid=2224739767"